Back to search
FDAFDA · Food and drugs·Recall number D-1873-2019

Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0097-55.

Published September 25, 2019 · Recall initiated: August 23, 2019

Summary

FDA records drug Class II recall D-1873-2019, published September 25, 2019 and initiated August 23, 2019. Recalling firm: Aurolife Pharma, LLC; Status: Terminated; Reported quantity: 4920 cartons; Lot: Lot #: 06718027A1, Exp 09/21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aurolife Pharma, LLC
Distributor
Nationwide in the USA
Lot
Lot #: 06718027A1, Exp 09/21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0097-55. recalled?

Yes. FDA published recall D-1873-2019 on September 25, 2019. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter